Cibc World Market Inc. Neurocrine Biosciences Inc Transaction History

Cibc World Market Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $1.62 Million - $1.93 Million	15,205 New	15,205 $1.82 Million
Q3 2018 Nov 09, 2018	SELL	$98.88 - $125.85 $1.04 Million - $1.32 Million	-10,481 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$75.3 - $105.99 $789,219 - $1.11 Million	10,481 New	10,481 $1.03 Million

635

93.5M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.